← FDA Drug Approvals (Drugs@FDA)

RYKINDO

NDA · New Drug Application · Sponsor: SHANDONG LUYE · Approved 2023-01-13

Drug application

FDA Application #

NDA212849

Application type

New Drug Application

Brand name

RYKINDO

Generic name

RISPERIDONE

Active ingredients

RISPERIDONE

Dosage form

FOR SUSPENSION, EXTENDED RELEASE

Route

INTRAMUSCULAR

Marketing status

Prescription

Sponsor

SHANDONG LUYE

Manufacturer

Shandong Luye Pharmaceutical Co., Ltd.

First approval

2023-01-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown